Owner of Stop & Shop, Giant grocery chains to pay – Business News
A large grocery store operator has agreed to pay $40 million to settle claims it reported inflated prescription costs to federal healthcare applications – which led the federal government to pay larger reimbursements than it ought to have.
Ahold Delhaize USA Inc. – the Quincy, Mass.-based operator of Stop & Shop, Giant, Hannaford and Food Lion – manages grocery shops with in-store pharmacies that offer prescription financial savings applications to members, in accordance to the Department of Justice.
Pharmacies with these financial savings applications are required to report the discounted costs as “usual and customary” costs on claims submitted to federal healthcare applications, in accordance to federal authorities.
A large grocery store operator has agreed to pay $40 million to settle claims it reported inflated prescription costs. Kristina Blokhin – stock.adobe.com
But as an alternative, Ahold Delhaize’s pharmacies reported the upper, pre-discount costs when billing Medicare Part D, Medicaid and TRICARE – prompting the federal government to pay inflated reimbursements, the DOJ alleged.
“Federal healthcare programs rely on pharmacies reporting accurate pricing information used in the applicable payment formulas,” Brett A. Shumate, assistant legal professional normal of the DOJ’s Civil Division, stated in a assertion final week.
“If pharmacies report inflated ‘usual and customary’ prices on claims to federal healthcare programs, the programs pay more than they should on those claims.”
Of the $40 million settlement, about $32.9 million will go towards the federal authorities, whereas the remaining can be paid to states collaborating within the case.
Lawrence LaBenne, a former pharmacist at an Ahold Delhaize grocery store in Pennsylvania and the whistleblower within the case, will obtain more than $6 million as half of the federal share of the settlement.
Pharmacies with financial savings applications are required to report the discounted costs as “usual and customary” costs. Valdemar – stock.adobe.com
“Pharmacies are trusted with charging the contracted prescription prices to Medicare and Medicaid and not unfairly and unlawfully taking advantage of the government and the public,” stated Troy Rivetti, US Attorney for the Western District of Pennsylvania.
“This settlement confirms that the United States will take all necessary steps to bring to justice dishonest pharmacies.”
The settlement was half of a coordinated effort between the DOJ’s Civil Division, Commercial Litigation Branch, Fraud Section and the US Attorney’s Office for the Western District of Pennsylvania, together with help from the Health Department, Defense Health Agency and state Medicaid applications.
